Document is current
Any future updates will be listed below
-
Authors
Cao, Kai
Xia, Yingda http://orcid.org/0000-0002-7478-4392
Yao, Jiawen http://orcid.org/0000-0001-7429-2964
Han, Xu
Lambert, Lukas
Zhang, Tingting
Tang, Wei
Jin, Gang
Jiang, Hui
Fang, Xu
Nogues, Isabella
Li, Xuezhou
Guo, Wenchao http://orcid.org/0000-0002-0445-1859
Wang, Yu
Fang, Wei
Qiu, Mingyan
Hou, Yang
Kovarnik, Tomas
Vocka, Michal http://orcid.org/0000-0002-9386-657X
Lu, Yimei
Chen, Yingli
Chen, Xin
Liu, Zaiyi
Zhou, Jian http://orcid.org/0000-0002-6868-9866
Xie, Chuanmiao
Zhang, Rong
Lu, Hong
Hager, Gregory D. http://orcid.org/0000-0002-6662-9763
Yuille, Alan L.
Lu, Le http://orcid.org/0000-0002-6799-9416
Shao, Chengwei http://orcid.org/0000-0002-9304-1252
Shi, Yu http://orcid.org/0000-0003-1940-0074
Zhang, Qi http://orcid.org/0000-0002-6096-0690
Liang, Tingbo http://orcid.org/0000-0003-0143-3353
Zhang, Ling http://orcid.org/0000-0001-8371-5252
Lu, Jianping http://orcid.org/0000-0002-0380-7470
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (82372045)
- License Information
-
More Information
Article History
Received: 9 February 2023
Accepted: 12 October 2023
First Online: 20 November 2023
Competing interests
: Alibaba group has filed for patent protection (application numbers: CN 202210575258.9, US 18046405) on behalf of Y.X., L.Z., J.Y., L. Lu and X. Hua for the work related to the methods of detection of pancreatic cancer in non-contrast CT. Y.X., J.Y., W.G., Y.W., W.F., M.Q., L. Lu and L.Z. are employees of Alibaba Group and own Alibaba stock as part of the standard compensation package. All other authors have no competing interests.
